Eijkman-Oxford Clinical Research Unit (EOCRU)

EOCRU was established in 2008 by a memorandum of understanding between the Eijkman Institute for Molecular Biology (EIMB) and the University of Oxford, as an embedded unit of the EIMB. These institutions now collaborate in clinical, laboratory, and field research on infectious diseases of public health importance in Indonesia. EOCRU is directed by Prof J. Kevin Baird and comprises three research groups and five supporting service groups.

The Eijkman-Oxford Clinical Research Unit (EOCRU), with its Indonesian hosts and partners, aims to collaboratively develop and pursue a research agenda of relevance to Indonesian healthcare providers and their patients. We are especially committed to infectious diseases that impose burdens of preventable or treatable morbidity and mortality in Southeast Asia, including tuberculosis, malaria, and other emerging and neglected infections. EOCRU’s vision is to compose an important and highly active centre of biomedical research excellence, with our hosts and partners, focusing on opportunities to improve the prevention, diagnosis, and treatment of these endemic infections by conducting robust randomized clinical trials that may directly impact practice and improve the health outcomes in Indonesia and the region.

Links

Displaying all articles

Muslim tetap menjaga jarak antarorang untuk hindari penularan coronavirus saat salat Jumat di sebuah masjid di Surabaya, 20 Maret 2020. EPA/FULLY HANDOKO

3 fakta yang jarang dilihat di balik tingginya persentase kematian COVID-19 di Indonesia

Penghitungan tingkat kematian di Indonesia tidak mencerminkan kenyataan di lapangan karena jumlah kasus positif yang dilaporkan diperkirakan jauh dari angka yang sebenarnya terjadi di masyarakat.
A nurse looks out of the isolation room for patients infected with COVID-19 at Undata Hospital, Palu, Central Sulawesi, Indonesia March 3, 2020. EPA/OPAN BUSTAN

Without major intervention, Indonesia could have 71,000 COVID-19 cases by April’s end

Massive COVID-19 rapid testing is starting this week in the several cities and regencies of coronavirus hot spot of Jakarta, West Java and Banten focusing on vulnerable groups.
Seorang perawat memandang dari ruangan isolasi untuk pasien terinfeksi COVID-19 di Rumah Sakit Undata Palu, Sulawesi Tengah, 3 Maret 2020. EPA/OPAN BUSTAN

Penularan COVID-19 di Indonesia bisa tembus 11-71 ribu akhir April jika tak ada intervensi cepat

Pertumbuhan COVID-19 yang begitu cepat juga terjadi di Italia, Iran, dan Korea Selatan. Ada kemungkinan orang terinfeksi namun belum terdeteksi atau tidak melapor.

Authors

More Authors